Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDAStephany Hiayev, Einat Shacham-Shmueli, Matitiahu Berkovitch, Ilana Weiss, Shai Ashkenazi, Michal Hirsch Vexberg, Rami Hershkowitz, Einat Gorelik, Haim Mayan, Yehudit Steinmetz, Noa Berar Yanai, Orly Schlissel, Muhammad Azem, Neriya Gutgold, Katerina ShulmanSee the full list of authors
4 May 2023
Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysisPing Yang, Yinyan Li, Xiaojuan Wang, Na Chen, Xiaoyang Lu
3 May 2023
Severity of coeliac disease and clinical management study when using a non-metabolised medication: a phase I pharmacokinetic studyMarc L Chretien, David G Bailey, Linda Asher, Jeremy Parfitt, David Driman, Jamie Gregor, George K Dresser
24 February 2023
Price and affordability of key essential medicines for children in Sri Lanka, a lower-middle-income country: comparison of two national cross-sectional surveys done 8 years apartShalini Sri Ranganathan, Thiyahiny Sunil Navaratinaraja, Ramasamy Balasubramaniam, Hemantha Beneragama
17 February 2023
Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and kneeMakoto Endo, Shinya Kawahara, Taishi Sato, Masami Tokunaga, Toshihiko Hara, Taro Mawatari, Tsutomu Kawano, Sadamoto Zenda, Tempei Miyaji, Mototsugu Shimokawa, Sanae Sakamoto, Toshio Takano, Masumi Miyake, Hiroyuki Aono, Yasuharu NakashimaSee the full list of authors
10 February 2023
Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims dataLisette Warkentin, Florian Klohn, Barthold Deiters, Thomas Kühlein, Susann Hueber
2 January 2023
Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C)Olga V Kravchenko, Richard D Boyce, Ainhoa Gomez-Lumbreras, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Charles E Leonard, Kathleen M Andersen, Hemalkumar Mehta, G Caleb Alexander, Daniel C Malone,
29 December 2022
Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysisSpoorthy Kulkarni, Hannah Durham, Luke Glover, Osaid Ather, Veronica Phillips, Szilard Nemes, Leslie Cousens, Parmis Blomgran, Philip Ambery
22 December 2022
Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective studyTanja Mueller, Amanj Kurdi, Elliott Hall, Ian Bullard, Jo Wapshott, Anna Goodfellow, Niketa Platt, Euan Proud, Stuart McTaggart, Marion Bennie, Aziz Sheikh, , on behalf of the EAVE II Collaboration, Colin R Simpson, Holly TibbleSee the full list of authors
5 December 2022
INSTIs for the management of HIV-associated TB (INSIGHT study): a phase 2b study to evaluate the efficacy, safety and pharmacokinetics of a combination of bictegravir, emtricitabine and tenofovir alafenamide fumarate for the treatment of HIV-1 infection in patients with drug-susceptible tuberculosis on a rifampicin-based treatment regimen: a phase 2b open-label randomised controlled trialAnushka Naidoo, Kelly E Dooley, Kogieleum Naidoo, Nesri Padayatchi, Nonhlanhla Yende-Zuma, Rubeshan Perumal, Gillian Dorse, Resha Boodhram, Emmanuella Chinonso Osuala
10 November 2022
